GENE ONLINE|News &
Opinion
Blog

Daniel Ojeda

WRITTEN BY Daniel Ojeda

Bristol Myers Squibb’s Deucravacitinib Impresses in Phase 3 Psoriasis Trial
2020-11-04
Lilly, Incyte Gaining Ground in the Fight against Alopecia Areata
2020-11-01
With their Respective Immunotherapy Drugs, Arcus, AstraZeneca Combine to Combat Lung Cancer
2020-11-01
Mirati’s Successful Targeting of the “Undruggable” Shapes Up Regulatory Showdown with Amgen
2020-10-28
Vir Biotechnology Showcases Data on a Potential Therapy for Influenza
2020-10-24
First to the Finish Line! Remdesivir Becomes the First and Only FDA Approved Drug to Treat COVID-19
2020-10-23
First of its Kind Therapy for Parkinson’s Disease Advances to Phase 2b Trials
2020-10-22
Eli Lilly Intends to Disarm Axonal Degeneration with Newest Acquisition
2020-10-17
Regeneron’s FDA Success with Ebola Treating Antibody Cocktail, Inmazeb, Bodes Well for its COVID-19 Candidate
2020-10-16
Lilly’s Investigational Monoclonal Antibody Registers Symptom Improvement in Crohn’s Disease Patients
2020-10-13
Scribe, Biogen Partner to Combat ALS using Nobel Prize-Winning CRISPR Technology
2020-10-08
Genentech Partners with AI-based Imaging Diagnostics Provider to Fight Lung Diseases
2020-10-07
Roche Collaborates with Blueprint Medicines to Develop Personalized Medicine for Lung and Thyroid Cancer
2020-07-19
Merck Reports Higher Efficacy for Islatravir Doravirine Combo in Adults with HIV-1 Infection
2020-07-09
Bavencio Bags FDA Approval as First-line Maintenance Treatment for Urothelial Carcinoma
2020-07-05
1 7 8 9
Scroll to Top